Schedule 13G ownership disclosure
NEOLEUKIN THERAPEUTICS INC
Security class unavailable · CUSIP: 64049K104
Event date: 2022-07-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001273087-22-000091
- Form type
- SC 13G
- Filer
- MILLENNIUM MANAGEMENT LLC
- CIK
- CIK 1273087
- Filed
- Jul 15, 2022
- Reporting period
- Jul 07, 2022
- Description
- Schedule 13G beneficial ownership